Form 4 for STTK Shattuck Labs, Inc.
Accepted 2023-01-27 00:00:00 ET · period of report 2023-01-25 · accession 0000899243-23-002884 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-01-27 | 2023-01-25 | STTK | Pandite Arundathy N. | Chief Medical Off | A - Grant | $0.00 | +37.9K | 175.8K | +27% | $0 |
| D | 2023-01-27 | 2023-01-25 | STTK | Pandite Arundathy N. | Chief Medical Off | A - Grant | $0.00 | +69.8K | 69.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-25 | A | A | 37,875 | $0.00 | 175,792 | D | — | — | (F1) Consists of 37,875 restricted stock units, which will vest in four equal annual installments beginning on January 25, 2024, subject to the Reporting Person's continued service to the Issuer. |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-01-25 | A | A | 69,750 | $0.00 | 69,750 | D | $3.57 · — to 2033-01-25 | 69,750 Common Stock | (F2) This option represents a right to purchase a total of 69,750 shares of the Issuer's common stock, one quarter of which will vest on January 25, 2024, with the remaining three quarters vesting in equal monthly installments through January 25, 2027, subject to the Reporting Person's continued service to the Issuer. |